Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab

A patient with COVID-19-related severe respiratory failure, with insufficient response to an antiretroviral therapy, hydroxychloroquine and Interleukin-6 (IL-6) antagonist therapy, presented a prompt resolution of the respiratory function and improvement in the radiological picture after baricitinib...

Descripción completa

Detalles Bibliográficos
Autores principales: Cingolani, A., Tummolo, A. M., Montemurro, G., Gremese, E., Larosa, L., Cipriani, M. C., Pasciuto, G., Liperoti, R., Murri, R., Pirronti, T., Cauda, R., Fantoni, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340855/
https://www.ncbi.nlm.nih.gov/pubmed/32642806
http://dx.doi.org/10.1007/s15010-020-01476-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340855/
https://www.ncbi.nlm.nih.gov/pubmed/32642806
http://dx.doi.org/10.1007/s15010-020-01476-7

Ejemplares similares